ALNY vs RVLV · P/E 76, rev $1.29B vs P/E 23, rev $690.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Revolve Group LLC (RVLV) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Revolve Group LLC (RVLV) is a internet retail company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported RVLV revenue for 2026-06-30 was $690.3M. Net income was $32.9M. RVLV currently screens at market cap $1.48B and trailing P/E 22.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. RVLV currently screens at market cap $1.48B and trailing P/E 22.9.
Not investment advice. Open the ALNY and RVLV stock pages for the full models.
Not investment advice.